ROME - Raisio has signed an agreement with Dr Schär that guarantess a strategic allegiance between the two companies going forwards.

 Dr. Schär, a leading global company in gluten-free foods, and Raisio, a forerunner in cholesterol-lowering foods, hope that their combined expertise will open new commercial opportunities for both.

 The long-term framework agreement outlines the essential contents of the strategic alliance. The companies are exploring opportunities for extensive collaboration in product development and manufacturing, amongst other areas of collaboration.

 Raisio and Dr. Schär see this strategic alliance as one that will add value for both companies. The collaboration also opens new opportunities for Raisio’s Benecol and Elovena brands in markets where Dr. Schär is particularly dominant, namely Germany, Italy, France and Spain.

 According to Raisio’s President and CEO Pekka Kuusniemi: “With its clear focus and high expertise in the markets of value-added products, Dr. Schär is an excellent partner for Raisio. Dr. Schär’s strong foothold in Europe complements Raisio’s geographical presence.”

 Dr. Schär’s CEO Ulrich Ladurner stated: “The strategic alliance with Raisio is an important step for us as it will enable us to further develop and strengthen our distribution network. In addition, Raisio’s value brands will complete our portfolio and we will get access to Raisio’s excellence in oats. As a family-owned company, it is important for us to know that the companies share the same core values.”

 Dr. Schär, based in Postal, Bolzano province, has been a pioneer in developing gluten-free products since 1922. With its extensive experience and know-how in R&D and marketing, Dr. Schär is the world’s leading company.

 Since 2014, Dr. Schär has expanded its area of activities by developing and commercialising special products in the field of medical nutrition. Dr. Schär has 1270 employees and 10 production plants. The net sales amounted to EUR 360 million in 2018.

gn